ABVX

6.71

2.04% -0.14

アフターアワーズ： 6.70 -0.010 -0.15%

Abivax Adr (ABVX)

概要ニュース株価時系列ディスカッション予測

前日終値:

$6.85

開ける：

$6.98

24時間の取引高:

17,236

Relative Volume:

0.09

時価総額：

$455.98M

収益：

当期純損益:

$-159.39M

株価収益率:

-1.8954

EPS:

-3.5401

ネットキャッシュフロー:

$-105.22M

1週間パフォーマンス:

-6.68%

1か月パフォーマンス:

+14.51%

6か月パフォーマンス:

-35.91%

1年パフォーマンス:

-52.58%

1日の値動き範囲:

$6.655

$6.99

1週間の範囲:

$6.54

$7.40

52週間の値動き範囲:

$4.77

$14.72

Abivax Adr Stock (ABVX) Company Profile

名前

Abivax Adr

セクター

Healthcare (1153)

産業

Biotechnology (676)

電話

住所

職員

Twitter

次回の収益日

2025-03-24

最新のSEC提出書

ABVX's Discussions on Twitter

ABVX を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
ABVX Abivax Adr	6.71	455.98M	0	-159.39M	-105.22M	-3.5401
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Abivax Adr Stock (ABVX) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-03-20	開始されました	Morgan Stanley	Equal-Weight
2024-12-04	開始されました	JMP Securities	Mkt Outperform
2024-07-29	開始されました	Laidlaw	Buy
2024-05-20	開始されました	BTIG Research	Buy
2024-04-29	開始されました	Guggenheim	Buy
2024-04-29	開始されました	Piper Sandler	Overweight
2023-11-14	開始されました	Leerink Partners	Outperform
2023-11-14	開始されました	Morgan Stanley	Equal-Weight

すべてを表示

Abivax Adr (ABVX) 最新ニュース

Apr 22, 2025

Abivax Announces AGM Details and Board Appointment Amid 2025 Milestones - TipRanks

Apr 22, 2025

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - GlobeNewswire Inc.

Apr 22, 2025

Apr 18, 2025

Abivax ADR (NASDAQ: ABVX) – Does It Provide Stability And Growth? - Stocksregister

Apr 18, 2025

Apr 08, 2025

Abivax Reports 2024 Financial Results, Eyes Clinical Milestones - TipRanks

Apr 08, 2025

Mar 27, 2025

Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating - TipRanks

Mar 27, 2025

Mar 25, 2025

Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength - TipRanks

Mar 25, 2025

Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment - TipRanks

Mar 25, 2025

Mar 24, 2025

Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position - TipRanks

Mar 24, 2025

Mar 18, 2025

Abivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025 - TipRanks

Mar 18, 2025

Mar 17, 2025

Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment - TipRanks

Mar 17, 2025

Mar 01, 2025

Wall Street Analysts See a 360.53% Upside in Abivax SA Sponsored ADR (ABVX): Can the Stock Really Move This High? - MSN

Mar 01, 2025

Feb 24, 2025

Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? - Nasdaq

Feb 24, 2025

Feb 11, 2025

Wall Street Analysts Think Abivax SA Sponsored ADR (ABVX) Could Surge 427.9%: Read This Before Placing a Bet - Yahoo Finance

Feb 11, 2025

Feb 10, 2025

Potential Price Increase for Abivax ADR (ABVX) After Recent Insider Activity - Knox Daily

Feb 10, 2025

Sibanye Stillwater Limited ADR (SBSW) rating downgrades by HSBC Securities - Knox Daily

Feb 10, 2025

Feb 07, 2025

Quantum Corp (QMCO) Stock: A Closer Look at the Market Potential - The News Heater

Feb 07, 2025

Analyzing the Price-to-Earnings Ratio of Abivax ADR (ABVX) - The News Heater

Feb 07, 2025

Capricor Therapeutics Inc (CAPR) Shares Plummet Below 1-Year High - The News Heater

Feb 07, 2025

Paylocity Holding Corp’s (PCTY) Stock: A Long-Term Performance Analysis - The News Heater

Feb 07, 2025

Perrigo Company plc (PRGO) Stock: A Closer Look at the Moving Averages - The News Heater

Feb 07, 2025

Analyzing the Price-to-Earnings Ratio of ICL Group Ltd (ICL) - The News Heater

Feb 07, 2025

Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater

Feb 07, 2025

Healthcare Triangle Inc (HCTI) Stock: A Closer Look at the Market Potential - The News Heater

Feb 07, 2025

Jan 30, 2025

Here's Why Abivax SA Sponsored ADR (ABVX) is Poised for a Turnaround After Losing -19.81% in 4 Weeks - MSN

Jan 30, 2025

Nov 19, 2024

Abivax ADR receives Investment Bank Analyst Rating Update By Investing.com - Investing.com

Apr 11, 2024

Oct 26, 2023

Citi Appointed as Depositary Bank for Abivax SA’s ADR Program - Business Wire

Oct 26, 2023

Abivax Adr (ABVX) 財務データ

収益

当期純利益

現金流量

EPS

INSM

$65.08

0.84%

GMAB

$19.36

0.31%

RPRX

$33.15

0.15%

SMMT

$23.96

2.80%

BNTX

$92.77

2.12%

ONC

$231.99

1.67%

Abivax Adr (ABVX)

Abivax Adr Stock (ABVX) Company Profile

ABVX を他の銘柄と比較する

Abivax Adr Stock (ABVX) Upgrades & Downgrades

Abivax Adr (ABVX) 最新ニュース

Abivax Announces AGM Details and Board Appointment Amid 2025 Milestones - TipRanks

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - GlobeNewswire Inc.

Abivax ADR (NASDAQ: ABVX) – Does It Provide Stability And Growth? - Stocksregister

Abivax Reports 2024 Financial Results, Eyes Clinical Milestones - TipRanks

Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating - TipRanks

Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength - TipRanks

Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment - TipRanks

Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position - TipRanks

Abivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025 - TipRanks

Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment - TipRanks

Wall Street Analysts See a 360.53% Upside in Abivax SA Sponsored ADR (ABVX): Can the Stock Really Move This High? - MSN

Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? - Nasdaq

Wall Street Analysts Think Abivax SA Sponsored ADR (ABVX) Could Surge 427.9%: Read This Before Placing a Bet - Yahoo Finance

Potential Price Increase for Abivax ADR (ABVX) After Recent Insider Activity - Knox Daily

Sibanye Stillwater Limited ADR (SBSW) rating downgrades by HSBC Securities - Knox Daily

Quantum Corp (QMCO) Stock: A Closer Look at the Market Potential - The News Heater

Analyzing the Price-to-Earnings Ratio of Abivax ADR (ABVX) - The News Heater

Capricor Therapeutics Inc (CAPR) Shares Plummet Below 1-Year High - The News Heater

Paylocity Holding Corp’s (PCTY) Stock: A Long-Term Performance Analysis - The News Heater

Perrigo Company plc (PRGO) Stock: A Closer Look at the Moving Averages - The News Heater

Analyzing the Price-to-Earnings Ratio of ICL Group Ltd (ICL) - The News Heater

Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater

Healthcare Triangle Inc (HCTI) Stock: A Closer Look at the Market Potential - The News Heater

Here's Why Abivax SA Sponsored ADR (ABVX) is Poised for a Turnaround After Losing -19.81% in 4 Weeks - MSN

Abivax Initiates $150 Million ATM Program on Nasdaq - TipRanks

Abivax Reports Strong Q3 Financials and Clinical Progress - TipRanks

Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks

Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks

Abivax SA Details Financial Struggles and Advances - TipRanks

Abivax ADR receives Investment Bank Analyst Rating Update By Investing.com - Investing.com

Citi Appointed as Depositary Bank for Abivax SA’s ADR Program - Business Wire

Abivax Adr (ABVX) 財務データ

収益

当期純利益

現金流量

EPS

ABVXに似た銘柄